Maravai Lifesciences Holdings Inc (MRVI) - News Archive

Maravai LifeSciences Welcomes Rajesh Asarpota as CFO Amidst Challenging TimesIn a move to bolster its leadership team, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI)—a global provider of life science reagents and se...

Legal Turmoil for Maravai LifeSciences: Shareholder Lawsuits Spark Concern Amidst Investor Discontent In recent weeks, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) has found itself embroiled in a series of legal c...

Maravai LifeSciences Holdings, Inc. Faces Legal Troubles Amid Lackluster Financial PerformanceOn April 23, 2025, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) found itself embroiled in a legal controversy as The Gr...

In recent developments, Bronstein, Gewirtz & Grossman LLC has announced its intention to lead a class action lawsuit for investors of Maravai LifeSciences Holdings, Inc. who have incurred substantial losses. This announ...

Maravai LifeSciences Holdings, Inc.: A Crucial Moment for Investors as Class Action Lawsuits Progress In recent weeks, investors in Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) have faced significant turmoil as a...

The landscape of pharmaceutical investments can be as unpredictable as the market itself. Nowhere is this more evident than with Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), which has recently found itself embroi...

: This article explores the unfolding class action lawsuit against Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), focusing on the securities litigation spearheaded by prominent law firms Levi & Korsinsky, LLP, and...

In an unfolding legal development, investors in Maravai Lifesciences Holdings, Inc. a prominent biotech firm, are being advised to take swift action regarding a significant securities class action lawsuit. According to...

: Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) is currently facing a securities class action lawsuit that invites affected investors to participate. This article synthesizes critical information from recent legal...

: This article examines the recent securities class action implicating Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI). It highlights the significant financial downturn experienced by the company and underscores the...

: In a dramatic turn of events, Maravai LifeSciences Holdings, Inc. finds itself at the center of a class action lawsuit following significant financial upheavals. With reported revenue plunges of over 70% year-over-yea...

Maravai LifeSciences Strengthens its Portfolio with Officinae Bio Acquisition: A New Era for RNA and mRNA DevelopmentIn a significant move that underscores its commitment to advancing life sciences, Maravai LifeSciences...

TriLink BioTechnologies and Johns Hopkins University Establish RNA Innovation Center to Propel Transformational Research and Therapeutic DevelopmentSAN DIEGO - TriLink BioTechnologies (TriLink), a leading global provide...

TriLink BioTechnologies and Lonza Sign Non-Exclusive Licensing and Supply Agreement for mRNA Sealing TechnologySan Diego, CA - TriLink BioTechnologies, a Maravai LifeSciences company and global provider of reagents and...

SAN DIEGO - TriLink BioTechnologies, a global provider of reagents and services for life sciences and a company of Maravai LifeSciences (NASDAQ: MRVI), has announced the inauguration of a new mRNA (messenger RNA) cGMP (...

TriLink BioTechnologies Expands mRNA Drug Production Capabilities with New San Diego FacilityTriLink BioTechnologies, a global life sciences company operating under Maravai LifeSciences, has announced the opening ceremo...

In recent years, mRNA-based therapeutics have emerged as a transformative approach in the field of biopharmaceutics, offering promising opportunities for the treatment of various diseases. Among the key players driving...